Intra-Cellular Therapies, Inc.

Erste Asset Management GmbH

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/14/2025

Shares

23,400

Value ($000)

3,084

Weight

0.0%

2020 Q3 - 2025 Q1 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/14/2025	3,084	0.0%	23,400	3/31/2025
2024 Q4	2/10/2025	1,985	0.0%	23,400	12/31/2024
2024 Q3	11/14/2024	1,715	0.0%	23,400	9/30/2024
2024 Q2	11/26/2024	1,661	0.0%	23,400	6/30/2024
2024 Q1	11/26/2024	1,631	0.0%	23,400	3/31/2024
2023 Q4	11/26/2024	1,685	0.0%	23,400	12/31/2023
2023 Q3	11/26/2024	1,259	0.0%	23,400	9/30/2023
2023 Q2	11/26/2024	1,450	0.0%	23,400	6/30/2023
2023 Q1	11/26/2024	1,312	0.0%	23,400	3/31/2023
2022 Q4	11/26/2024	1,253	0.0%	23,400	12/31/2022
2022 Q3	11/26/2024	1,059	0.0%	23,400	9/30/2022
2022 Q2	11/26/2024	1,364	0.0%	23,400	6/30/2022
2022 Q1	11/25/2024	1,411	0.0%	23,400	3/31/2022
2021 Q4	11/25/2024	1,087	0.0%	21,000	12/31/2021
2021 Q3	11/25/2024	752	0.0%	21,000	9/30/2021
2021 Q2	11/25/2024	835	0.0%	21,000	6/30/2021
2021 Q1	11/25/2024	683	0.0%	21,000	3/31/2021
2020 Q4	11/25/2024	655	0.0%	21,000	12/31/2020
2020 Q3	11/25/2024	536	0.0%	21,000	9/30/2020